Fewer Injections, Same Results? The Truth About GLP-1 Dosing
Share
What Are GLP-1 Medications?
GLP-1 receptor agonists are a type of medication used to treat obesity and type 2 diabetes. They work by copying the effects of a natural hormone that helps reduce hunger and control blood sugar. Popular drugs in this category include semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound).
These medications have shown impressive results in clinical trials, helping people lose 15–20% of their body weight. That’s far more than older weight loss medications.
The Problem: High Cost and Shortages
Despite their effectiveness, GLP-1 drugs are expensive—often over $1,000 a month without insurance. They’re also in high demand, leading to frequent supply issues. Some people find themselves skipping doses or unable to refill their prescriptions.
This has led doctors and patients to ask an important question: Can you take GLP-1 drugs less often and still keep the weight off?
Real People, Real Results
A recent study looked at two patients who tried using GLP-1 medications less frequently than recommended.
- Case 1: A man in his 30s lost 40 pounds on semaglutide. When he couldn’t get regular refills, he started spacing his injections to every 10–14 days. He continued walking daily, eating better, and managed to lose even more weight—eventually maintaining a loss of over 70 pounds.
- Case 2: A woman in her 50s with diabetes and obesity lost 54 pounds and was able to stop insulin. Even when she had to go weeks without her medication due to shortages, she kept her weight steady by following a low-carb diet and eating smaller portions.
What the Science Says
To support these real-life stories, researchers also used computer models to simulate how people would respond to different dosing schedules. They tested what would happen if someone took the drug every 10, 14, or even 28 days instead of weekly.
The surprising result? People still maintained a large part of their weight loss—even with fewer doses.
For example:
- Taking semaglutide every 2 weeks instead of weekly still kept about 72% of the weight loss.
- Taking tirzepatide every 4 weeks still maintained about 50% of the weight loss.
This means fewer injections might still give meaningful benefits, especially when combined with healthy habits like good nutrition and regular exercise.
What This Means for You
If you’re using GLP-1 medications or considering them, this research gives some hope. Taking fewer doses could:
- Help stretch out your medication during shortages
- Reduce costs if you're paying out-of-pocket
- Make long-term use more manageable
But it’s important to note: this strategy isn’t officially approved and doesn’t work for everyone. Always talk to your doctor before changing your medication schedule.
Final Thoughts
GLP-1 medications are changing the game for weight loss and diabetes, but cost and access remain big challenges. Early evidence suggests that taking these drugs less frequently may still work for some people.
It’s not a one-size-fits-all solution, but it could be a helpful option for those who want to maintain their progress without constant weekly injections. More research is needed, but this approach is worth watching—and discussing with your healthcare provider.